News

Net profit of Norris Medicines reported to Rs 0.05 crore in the quarter ended March 2026 as against net loss of Rs 0.23 crore during the previous quarter ended March 2025. Sales declined 48.16% to Rs 1.41 crore in the quarter ended March 2026 as against Rs 2.72 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 0.28 crore in the year ended March 2026 as against net loss of Rs 1.24 crore during the previous year ended March 2025. Sales rose 39.69% to Rs 8.13 crore in the year ended March 2026 as against Rs 5.82 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1.412.72 -48 8.135.82 40 OPM %21.282.57 -8.12-4.47 - PBDT0.17-0.03 LP 0.21-0.64 LP PBT0.05-0.17 LP -0.28-1.18 76 NP0.05-0.23 LP -0.28-1.24 77 Powered by Capital Market - Live News

Norris Medicines will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live News

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Norris Medicines announced that the 34th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live News